Navigation Links
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
Date:5/20/2008

that utilizes MMX(R) Technology. LIALDA with MMX Technology combines a pH dependent gastro-resistant coating, which delays the release of the medication to the colon (the site of the inflammation in ulcerative colitis), with a tablet core containing mesalamine with hydrophilic and lipophilic components.

Shire has licensed from Giuliani SpA the exclusive rights to develop and commercialize LIALDA in the US, Canada, Pacific Rim, and Europe (excluding Italy). LIALDA is known as MEZAVANT XL(TM) in the UK and Ireland, and MEZAVANT(R) elsewhere outside of the US. Giuliani SpA retains the development and commercialization rights in Italy. Cosmo Pharmaceuticals SpA, Milan, developed the MMX technology.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger, and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

For further information please contact:

Media Sarah McGee (GolinHarris) +1 312 729 4125

Matthew Cabrey (Shire) +1 484 595 8248

About DDW

DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscop
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Texas , March 3, 2015  UnaliWear announces ... provides advanced support for seniors that guards against wandering ... The new wearable – the Kanega watch ... its kind to use an easy speech interface rather ... medical information without human input. The ...
(Date:3/3/2015)... -- American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) a ... in the design, development and production of innovative ... device companies has announced the acquisition of MTI ... cable manufacturer based in North Carolina.  The new ... name MTI Medical Cables.  The ...
(Date:3/3/2015)... Ariz. , March 3, 2015  Michigan brothers ... heart condition called arrhythmogenic right ventricular dysplasia, or ARVD, a ... cause of sudden death among young athletes. In ... at a basketball game. They later tested Dominique and found ... to a February 19, 2015 story in The Ann ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2American Biosurgical Acquires MTI Corporation 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
(Date:3/4/2015)... Follow us on LinkedIn ... worldwide. The rising prevalence of high blood pressure in ... both developed and developing countries. By 2025, the number ... 1.5 billion, equating to approximately 30% of the total ... to come from the developing countries. Major lifestyle factors ...
(Date:3/4/2015)... March 04, 2015 Developers of FCPX ... a new overlay plugin for Final Cut Pro X entitled ... Overlays Lens Dirt gives users total control over 6k lens ... CEO of Pixel Film Studios. “FCPX Overlays Lens Dirt was ... easy to use interface.” , FCPX Overlays Lens Dirt from ...
(Date:3/4/2015)... March 04, 2015 The medical device ... whose management forgot – or ignored or didn't know ... the market based on physician input before proceeding to ... more specifically, founders – become so enamored of an ... question: Will physicians use the device?” says Dr. ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio ... District Court for the Northern District of Ohio against ... insurance companies Balboa, QBE, and Newport Management. (See Amended ... , The Plaintiff, a Ms. Dolores Gorsuch, says her ... to buy too much insurance at rates that were ...
(Date:3/3/2015)... March 03, 2015 Longtime parent visionary ... CARE Surrogacy Center for a candid interview ... appearing online is an exhilarating revelation of his magical ... led him from Australia to the birth of his ... interchange, Tolga Umar, CEO and Founder of CARE stated, ...
Breaking Medicine News(10 mins):Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Pixel Film Studios released a New Overlay Plugin entitled FCPX Overlays Lens Dirt Exclusively for Final Cut Pro X users 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3
... HealthDay Reporter , THURSDAY, Dec. 9 (HealthDay News) ... potentially promising weapon against breast cancer recurrence, has flopped ... Zometa did not appear to prevent breast cancer ... researchers presented the disappointing findings Thursday at the San ...
... A new study challenges the theory that lowering the minimum ... binge drinking by college students. Some college presidents and ... bars and restaurants, they might learn more moderate drinking habits, ... college campuses. The idea is being promoted through an effort ...
... Ewa Kuligowska-Noble, MD, FACR, a radiologist at Boston ... Boston University School of Medicine (BUSM), is the recipient ... Association for Women Radiologists. The award, which is presented ... contribution to the field of radiology, was given to ...
... demands on a couple seeking fertility treatment can be daunting. ... fertility to increase a couple,s chances of becoming pregnant in ... Infants Hospital is one of the centers participating in a ... fertility drug. This new drug would require one weekly ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, ... to counter the prevailing wisdom that any form of hormone ... look at some old data suggests that estrogen-only hormone therapy ... disease. "Exogenous estrogen [such as hormone therapy] is actually ...
... have argued that lowering the minimum legal drinking age could help ... issue of the Journal of Studies on Alcohol and Drugs ... In 2008, a group of college presidents and ... minimum legal drinking age of 21. They argue that the law ...
Cached Medicine News:Health News:Bone Drug Zometa Flops Overall as Breast Cancer Treatment 2Health News:Bone Drug Zometa Flops Overall as Breast Cancer Treatment 3Health News:BMC radiologist receives 2010 Marie Sklodowska-Curie Award from AAWR 2Health News:Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some 2Health News:Estrogen-Only Hormone Therapy May Reduce Breast Cancer Risk for Some 3Health News:Lowering the drinking age is unlikely to curb college binge drinking 2
Ideal for abdominal procedures...
... in the abdominal area for the taller, ... and eye closures extend the full,length of ... very thin zipper opens the garment completely. ... gripper lace trim, and adjustable detachable straps ...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks & knees...
White Standard Girdle...
Medicine Products: